Cost-effectiveness of single-dose tamsulosin and dutasteride combination therapy compared with tamsulosin monotherapy in patients with benign prostatic hyperplasia in the UK
Author:
Affiliation:
1. Heron Evidence Development Ltd; Luton UK
2. GlaxoSmithKline; Health Outcomes UK; Uxbridge UK
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11659.x/fullpdf
Reference34 articles.
1. Prevalence of lower urinary tract symptoms and self reported diagnosed ‘benign prostatic hyperplasia’, and their effect on quality of life in a community based survey of men in the UK;Trueman;BJU Int,1999
2. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care - the Triumph project;Verhamme;Eur Urol,2002
3. Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men;Garraway;Br J Gen Pract,1993
4. Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: the Prostate Research on Behaviour and Education (PROBE). Survey;Emberton;Int J Clin Pract,2008
5. Genitourinary neurofibromatosis mimicking posterior urethral valves;Brown;Urology,1997
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Management of benign prostate hyperplasia (BPH) by combinatorial approach using alpha-1-adrenergic antagonists and 5-alpha-reductase inhibitors;European Journal of Pharmacology;2020-09
2. Cost-Effectiveness of Robot-assisted Radical Cystectomy Using a Propensity-matched Cohort;European Urology Focus;2020-01
3. Cost-Effectiveness of Combination Therapy Versus Monotherapy in Benign Prostatic Hyperplasia: A Colombian Experience;Value in Health Regional Issues;2018-12
4. Economic Evaluation of Combination Therapy Versus Monotherapy for Treatment of Benign Prostatic Hyperplasia in Hong Kong;Frontiers in Pharmacology;2018-10-16
5. Tratamiento de la hiperplasia benigna de próstata mediante embolización arterial;EMC - Urología;2018-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3